ATE281464T1 - Adenosinderivate und deren verwendung - Google Patents

Adenosinderivate und deren verwendung

Info

Publication number
ATE281464T1
ATE281464T1 AT01963522T AT01963522T ATE281464T1 AT E281464 T1 ATE281464 T1 AT E281464T1 AT 01963522 T AT01963522 T AT 01963522T AT 01963522 T AT01963522 T AT 01963522T AT E281464 T1 ATE281464 T1 AT E281464T1
Authority
AT
Austria
Prior art keywords
adenosine
hexyn
cyano
compounds
drugs
Prior art date
Application number
AT01963522T
Other languages
English (en)
Inventor
Takashi Konno
Iizakamachi Yuno
Kazuhiro Uemoto
Shinya Onuma
Yoshikazu Kato
Original Assignee
Toa Eiyo Ltd
Yamasa Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Toa Eiyo Ltd, Yamasa Corp filed Critical Toa Eiyo Ltd
Priority claimed from PCT/JP2001/007791 external-priority patent/WO2002020540A1/ja
Application granted granted Critical
Publication of ATE281464T1 publication Critical patent/ATE281464T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16Purine radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7076Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0048Eye, e.g. artificial tears
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • A61P27/06Antiglaucoma agents or miotics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16Purine radicals
    • C07H19/20Purine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
AT01963522T 2000-09-08 2001-09-07 Adenosinderivate und deren verwendung ATE281464T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2000272979 2000-09-08
PCT/JP2001/006922 WO2002020539A1 (fr) 2000-09-08 2001-08-10 Derives d'adenosine et leur utilisation
PCT/JP2001/007791 WO2002020540A1 (fr) 2000-09-08 2001-09-07 Dérivés d'adénosine et leurs applications

Publications (1)

Publication Number Publication Date
ATE281464T1 true ATE281464T1 (de) 2004-11-15

Family

ID=18759008

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01963522T ATE281464T1 (de) 2000-09-08 2001-09-07 Adenosinderivate und deren verwendung

Country Status (6)

Country Link
US (2) US6936596B2 (de)
JP (1) JPWO2002020540A1 (de)
AT (1) ATE281464T1 (de)
AU (1) AU2001278708A1 (de)
DE (1) DE60106953T2 (de)
WO (1) WO2002020539A1 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6232297B1 (en) * 1999-02-01 2001-05-15 University Of Virginia Patent Foundation Methods and compositions for treating inflammatory response
US7378400B2 (en) * 1999-02-01 2008-05-27 University Of Virginia Patent Foundation Method to reduce an inflammatory response from arthritis
US7427606B2 (en) * 1999-02-01 2008-09-23 University Of Virginia Patent Foundation Method to reduce inflammatory response in transplanted tissue
EP1434782A2 (de) * 2001-10-01 2004-07-07 University of Virginia Patent Foundation 2-propynyladenosine-analoge mit a2a-agonistischer aktivität and diese enthaltende gemische
US20090170803A1 (en) * 2002-04-10 2009-07-02 Linden Joel M Adjunctive treatment of biological diseases
EP1464708A1 (de) * 2003-04-03 2004-10-06 Pro. Bio. Sint. S.p.A. Verfahren zur Herstellung von Fludarabinphosphat aus 2-Fluoroadenin
WO2006023272A1 (en) * 2004-08-02 2006-03-02 University Of Virginia Patent Foundation 2-polycyclic propynyl adenosine analogs having a2a agonist activity
US7576069B2 (en) * 2004-08-02 2009-08-18 University Of Virginia Patent Foundation 2-polycyclic propynyl adenosine analogs having A2A agonist activity
JP5046930B2 (ja) * 2004-08-02 2012-10-10 ユニバーシティ オブ バージニア パテント ファウンデーション A2aアゴニスト活性を有する修飾5’−リボース基を備えた2−プロピニルアデノシン類似体
WO2007092936A2 (en) * 2006-02-08 2007-08-16 University Of Virginia Patent Foundation Method to treat gastric lesions
WO2007120972A2 (en) 2006-02-10 2007-10-25 University Of Virginia Patent Foundation Method to treat sickle cell disease
US8188063B2 (en) * 2006-06-19 2012-05-29 University Of Virginia Patent Foundation Use of adenosine A2A modulators to treat spinal cord injury
US8058259B2 (en) * 2007-12-20 2011-11-15 University Of Virginia Patent Foundation Substituted 4-{3-[6-amino-9-(3,4-dihydroxy-tetrahydro-furan-2-yl)-9H-purin-2-yl]-prop-2-ynyl}-piperidine-1-carboxylic acid esters as A2AR agonists
KR20150138182A (ko) * 2013-03-15 2015-12-09 이노텍 파마슈티컬스 코포레이션 안구 신경보호를 제공하는 방법

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57140716A (en) 1981-02-24 1982-08-31 Yamasa Shoyu Co Ltd Antiallergic agent
JPH07106983B2 (ja) 1987-12-02 1995-11-15 三共株式会社 グリゼオール酸ジエステル誘導体
US5270304A (en) 1988-11-15 1993-12-14 Yamasa Shoyu Kabushiki Kaisha Therapeutic 2-alkynyl adenosine agent for ischemic diseases of the heart or brain
US5039797A (en) 1989-10-13 1991-08-13 Yale University 2'-O-(4-benzoyl)benzoyl nucleoside cyclic monophosphate
US5189027A (en) 1990-11-30 1993-02-23 Yamasa Shoyu Kabushiki Kaisha 2-substituted adenosine derivatives and pharmaceutical compositions for circulatory diseases
JP3053908B2 (ja) * 1991-06-28 2000-06-19 ヤマサ醤油株式会社 2‐アルキニルアデノシン誘導体
JP3025557B2 (ja) 1991-06-28 2000-03-27 ヤマサ醤油株式会社 2‐アルキニルアデノシン誘導体
FR2685918B1 (fr) 1992-01-08 1995-06-23 Union Pharma Scient Appl Nouveaux derives de l'adenosine, leurs procedes de preparation, compositions pharmaceutiques les contenant.
IT1254915B (it) * 1992-04-24 1995-10-11 Gloria Cristalli Derivati di adenosina ad attivita' a2 agonista
JP2002173427A (ja) * 1998-09-01 2002-06-21 Yamasa Shoyu Co Ltd 眼疾患治療用医薬組成物
JP2003055395A (ja) 2001-08-10 2003-02-26 Toa Eiyo Ltd アデノシン誘導体

Also Published As

Publication number Publication date
DE60106953T2 (de) 2005-04-28
JPWO2002020540A1 (ja) 2004-01-15
AU2001278708A1 (en) 2002-03-22
WO2002020539A1 (fr) 2002-03-14
US20040053881A1 (en) 2004-03-18
DE60106953D1 (de) 2004-12-09
US6936596B2 (en) 2005-08-30
US7132409B2 (en) 2006-11-07
US20050130930A1 (en) 2005-06-16

Similar Documents

Publication Publication Date Title
DE60106953D1 (de) Adenosinderivate und deren verwendung
TR200200579T2 (tr) Amino-tirazolpiridin türevleri.
AU2804400A (en) Phenyl urea and phenyl thiourea derivatives as orexin receptor antagonists
BR0113757A (pt) Derivados de quinolinona como inibibores de tirosina quinase
MA27040A1 (fr) Nucleosides substitues en 4'
DK1110554T3 (da) Medicinal præparater til behandling af öjensygdomme
TR200101499T1 (tr) Azepinoindol türevleri, hazırlanmaları ve kullanımları.
ES2095833T3 (es) Derivados de benzodiazepinas.
ATE312076T1 (de) Thiol-modifizierte hyaluronan-derivate
KR970704435A (ko) 헤테로시클릭 화합물의 도파민-D 리간드로서의 용도(Use of Heterocyclic Compounds as Dopamines-D Ligands)
SV2002000245A (es) Oxazolidinonas substituidas y su uso ref. lea 34122-sv
ES2167377T3 (es) Derivados de piridina farmacologicamente activos y procedimientos para la preparacion de los mismos.
TR200100694T2 (tr) Opioid alıcı aktivitesine sahip 4,4-Biarilpiperidin türevleri
TR200000223T2 (tr) XA faktörünü engelleyen heterosiklik türevler
DE68906609D1 (de) Dopamin-vorlaeufer.
SE0302573D0 (sv) Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
NO20072089L (no) Benzimidazolderivater, sammensetninger som inneholder dem, fremstilling derav og anvendelse derav
TR200102008T2 (tr) Serebral işemi profilaksı ve tedavisi için piridin türevlerinin kullanımı.
SE0302570D0 (sv) Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
DE60013126D1 (de) Ophthalmische histamin-enthaltende zusammensetzungen und deren verwendung
SE0302572D0 (sv) Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
TR199800165T1 (xx) (R)-5-bromo-n-(1-etil-4-metil hekzahidro-1h-1,4-diazepin-6-il)-2-metoksi-6- metilamino-3-piridinkarboksamid, bunu haz�rlamaya mahsus y�ntem ve bu bile�i�i ihtiva eden farmas�tik terkip.
ATE141796T1 (de) 2',5'-oligoadenylat-derivate zur verwendung als heilmittel
NO980058L (no) Opthalmiske preparater
ATE285771T1 (de) Diaminotrifluoromethylpyrimidinderivate enthaltende antikrebs-zusammensetzung

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties